Literature DB >> 21807636

Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.

Beatriz Soldevilla1, Raquel Díaz, Javier Silva, Yolanda Campos-Martín, Concepción Muñoz, Vanesa García, José M García, Cristina Peña, Mercedes Herrera, Marta Rodriguez, Irene Gómez, Nagat Mohamed, Margarita M Marques, Félix Bonilla, Gemma Domínguez.   

Abstract

PURPOSE: Cumulative data support the role of ΔTAp73 variants in tumorigenic processes such as drug resistance. We evaluate the impact of TP73 isoforms and their putative target genes ABCB1, HMGB1, and CASP1 on the survival of colon cancer patients and the correlation between their expressions. EXPERIMENTAL
DESIGN: We determined in 77 colon cancer patients the expression of ΔEx2p73, ΔEx2/3p73, ΔNp73, TAp73, ABCB1, HMGB1, and CASP1 by quantitative real-time reverse transcriptase-PCR. Tumor characteristics, disease-free survival, and overall survival (OS) were examined in each patient. Functional experiments were carried out to check whether ectopic expression of ΔNp73 modifies the proliferation, drug resistance, migration, and invasion properties of colon tumor cells and the expression of ABCB1, HMGB1, and CASP1.
RESULTS: Positive correlations were observed between the expression levels of ΔTAp73 variants and HMGB1. Furthermore, a trend was observed for ABCB1. Overexpression of ΔEx2/3p73 and ΔNp73 isoforms was significantly associated with advanced stages (P = 0.04 and P = 0.03, respectively) and predicted shortened OS (P = 0.04 and P = 0.05, respectively). High levels of ABCB1 and HMGB1 were associated with shorter OS (P = 0.04 and P = 0.05, respectively). Multivariate analysis showed that, in addition to the tumor stage, ABCB1 and HMGB1 had independent relationships with OS (P = 0.008). Ectopic expression of ΔNp73 was associated with an increase in proliferation and drug resistance.
CONCLUSIONS: The positive correlation between ΔTAp73 variants and HMGB1 and ABCB1 expression supports them as TP73 targets. The fact that upregulation of ΔTAp73 isoforms was associated with shortened OS, increase in proliferation, and drug resistance confirms their oncogenic role and plausible value as prognostic markers. ABCB1 and HMGB1, putative ΔTAp73 target genes, strongly predict OS in an independent manner, making clear the importance of studying downstream TP73 targets that could predict the outcome of colon cancer patients better than ΔTAp73 variants themselves do. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807636     DOI: 10.1158/1078-0432.CCR-10-2388

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

1.  Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.

Authors:  Erika Mikulenkova; Jakub Neradil; Karel Zitterbart; Jaroslav Sterba; Renata Veselska
Journal:  Tumour Biol       Date:  2015-04-25

2.  ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).

Authors:  M I Prieto-Nieto; D Pastor; J Rodríguez-Cobos; J P Pérez; C Méndez; E Palacios; M Arranz-Alvarez; J Santos-López; M Cano-Vega; D Viñal; N Rodríguez; G Domínguez
Journal:  Clin Transl Oncol       Date:  2019-10       Impact factor: 3.405

Review 3.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

4.  High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Authors:  Antonio R Lucena-Araujo; Haesook T Kim; Carolina Thomé; Rafael H Jacomo; Raul A Melo; Rosane Bittencourt; Ricardo Pasquini; Katia Pagnano; Ana Beatriz F Glória; Maria de Lourdes Chauffaille; Melina Athayde; Carlos S Chiattone; Ingrid Mito; Rodrigo Bendlin; Carmino Souza; Cristina Bortolheiro; Juan L Coelho-Silva; Stanley L Schrier; Martin S Tallman; David Grimwade; Arnold Ganser; Nancy Berliner; Raul C Ribeiro; Francesco Lo-Coco; Bob Löwenberg; Miguel A Sanz; Eduardo M Rego
Journal:  Blood       Date:  2015-10-01       Impact factor: 22.113

Review 5.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

6.  BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression.

Authors:  Qiong Wu; Fangfang Liu; Mengmeng Ge; Kyle Vaughn Laster; Lixiao Wei; Ruijuan Du; Ming Jiang; Jing Zhang; Yafei Zhi; Guoguo Jin; Simin Zhao; Dong Joon Kim; Zigang Dong; Kangdong Liu
Journal:  Oncogene       Date:  2021-11-08       Impact factor: 9.867

7.  Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Authors:  Danae Papadogianni; Nikolaos Soulitzis; Demetrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2013-11-11

Review 8.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

10.  ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer.

Authors:  Javier Rodríguez-Cobos; David Viñal; Carmen Poves; María J Fernández-Aceñero; Héctor Peinado; Daniel Pastor-Morate; Mª Isabel Prieto; Rodrigo Barderas; Nuria Rodríguez-Salas; Gemma Domínguez
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.